Advances in Tobacco Control

Cigarette smoking is the leading cause of death from lung cancer in the United States. That’s why November, Lung Cancer Awareness Month, is a good time to highlight new advances in tobacco control, such as the legislation that came into effect Nov. 1, 2017, in New Jersey that raises the minimum age of legal access to tobacco products to 21.

Read More

AACR Cancer Progress Report 2017: Harnessing Research Discoveries to Save Lives

Today, the American Association for Cancer Research (AACR) released its seventh annual Cancer Progress Report. The report highlights how federally funded research that provides a deep understanding of the biology of cancer is spurring advances across the clinical cancer care continuum that are improving survival and quality of life for people around the world.

Read More

AACR Cancer Progress Report 2016: Saving Lives Through Research

Today, the American Association for Cancer Research (AACR) released its sixth annual Cancer Progress Report. The report highlights how federally funded research powers progress against cancer and warns that accelerating …

Read More

Federally Funded Research Can Power Progress Against Cancer

Today, the American Association for Cancer Research (AACR) released the results of a national survey on American voter’s opinions about cancer and cancer research funding in conjunction with its fifth annual Cancer Progress Report. The report highlights how federally funded research can power progress against cancer and urges Congress and the administration to prioritize the growth of the budgets of the National Institutes of Health (NIH), National Cancer Institute (NCI), and U.S. Food and Drug Administration (FDA).

Read More

First FDA-approved Treatment for Rare Form of Non-Hodgkin Lymphoma

Last week, the U.S. Food and Drug Administration (FDA) announced the first-ever approval of a treatment for Waldenström macroglobulinemia, ibrutinib (Imbruvica).
Waldenström macroglobulinemia, which is also known as lymphoplasmacytic lymphoma, is …

Read More

Progress Against Cancer: An Ongoing Goal That Needs Increased Federal Investment

Carlos L. Arteaga, MD, immediate past-president of the AACR.

In follow up to the AACR Cancer Progress Report 2014, AACR President Carlos L. Arteaga, MD, discusses our continuing progress against cancer, including recent FDA decisions that provide patients with new options for cancer prevention and treatment, and the continuing need for federal investment in biomedical research.

Read More